Immix Biopharma, Inc. (IMMX) has shared an announcement.
At Immix Biopharma, Inc.’s 2024 Annual Meeting, shareholders cast their votes on pivotal company proposals, with a strong turnout of 70.4% of the voting shares. They overwhelmingly approved the election of new directors, the ratification of KMJ Corbin & Company LLP as the independent auditor for the upcoming year, and amendments to the 2021 Omnibus Equity Incentive Plan. These amendments included an increase in shares available for issuance and the adoption of an evergreen provision allowing automatic annual increases in available shares for the next ten years, reflecting the company’s commitment to growth and shareholder value.
For detailed information about IMMX stock, go to TipRanks’ Stock Analysis page.
